R33G (p.Arg33Gly) variant of ABL2 (Tyrosine-protein kinase ABL2)
R33G (p.Arg33Gly) in ABL2 (Tyrosine-protein kinase ABL2) is a missense change. The available variant effect predictions contribute to a CATVariant prioritization score of 0.56 / 1. The record also includes population frequency data.
R33G (p.Arg33Gly) variant details
- p.Arg33Gly
- ExAC rs747516775
- TOPMed rs747516775
- gnomAD rs747516775
- Missense
- Variant Prioritization Score for Impact Estimate 0.556
- REVEL 0.44
- CADD 23.10
- Population evidence available